Creative Planning’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-428,977
| Closed | -$6.2M | – | 4345 |
|
|
2026
Q1 | $6.2M | Buy |
428,977
+26,572
| +7% | +$381K | ﹤0.01% | 1025 |
|
|
2025
Q4 | $5.73M | Buy |
402,405
+21,382
| +6% | +$210K | ﹤0.01% | 911 |
|
|
2025
Q3 | $3M | Buy |
381,023
+164,744
| +76% | +$1.17M | ﹤0.01% | 1226 |
|
|
2025
Q2 | $1.24M | Buy |
216,279
+180,652
| +507% | +$1.17M | ﹤0.01% | 1678 |
|
|
2025
Q1 | $291K | Sell |
35,627
-49,883
| -58% | -$462K | ﹤0.01% | 2782 |
|
|
2024
Q4 | $806K | Buy |
85,510
+32,655
| +62% | +$339K | ﹤0.01% | 1826 |
|
|
2024
Q3 | $564K | Buy |
52,855
+23,433
| +80% | +$255K | ﹤0.01% | 1987 |
|
|
2024
Q2 | $292K | Sell |
29,422
-4,502
| -13% | -$46.2K | ﹤0.01% | 2372 |
|
|
2024
Q1 | $400K | Buy |
33,924
+9,022
| +36% | +$115K | ﹤0.01% | 2025 |
|
|
2023
Q4 | $353K | Buy |
24,902
+7,952
| +47% | +$90.3K | ﹤0.01% | 1977 |
|
|
2023
Q3 | $206K | Buy |
16,950
+2,937
| +21% | +$37.9K | ﹤0.01% | 2221 |
|
|
2023
Q2 | $176K | Buy |
+14,013
| New | +$166K | ﹤0.01% | 2244 |
|
|
2017
Q4 | – | Sell |
-10,343
| Closed | -$156K | – | 1942 |
|
|
2017
Q3 | $156K | Buy |
10,343
+70
| +0.7% | +$926 | ﹤0.01% | 1656 |
|
|
2017
Q2 | $103K | Sell |
10,273
-6,127
| -37% | -$49.3K | ﹤0.01% | 1973 |
|
|
2017
Q1 | $117K | Buy |
16,400
+5,900
| +56% | +$37.3K | ﹤0.01% | 1849 |
|
|
2016
Q4 | $52K | Buy |
10,500
+400
| +4% | +$2.77K | ﹤0.01% | 2357 |
|
|
2016
Q3 | $75K | Hold |
10,100
| – | – | ﹤0.01% | 2052 |
|
|
2016
Q2 | $55K | Sell |
10,100
-10,000
| -50% | -$69.9K | ﹤0.01% | 2077 |
|
|
2016
Q1 | $170K | Buy |
20,100
+10,000
| +99% | +$70.8K | ﹤0.01% | 1295 |
|
|
2015
Q4 | $98K | Buy |
+10,100
| New | +$91K | ﹤0.01% | 1639 |
|
|
2015
Q1 | – | Sell |
-1,200
| Closed | -$10K | – | 4278 |
|
|
2014
Q4 | $10K | Sell |
1,200
-300
| -20% | -$2.06K | ﹤0.01% | 3116 |
|
|
2014
Q3 | $9K | Buy |
+1,500
| New | +$7.86K | ﹤0.01% | 2995 |
|
Other funds holding FOLD
Creative Planning's FOLD Position: Q2 2026 in Review
Creative Planning sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 428,977 shares — an estimated $6.2M sold.
Creative Planning first reported a position in FOLD in Q3 2014 and held it in 22 quarters. The position peaked at $6.2M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Creative Planning reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Creative Planning sold 428,977 Amicus Therapeutics shares in Q2 2026, an estimated $6.2M.
- Creative Planning first reported a position in Amicus Therapeutics in Q3 2014 and held it in 22 quarters.
- Creative Planning's Amicus Therapeutics position peaked at $6.2M in Q1 2026.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.